Arrhythmias & electrophysiologyCohort study

Prediction of ventricular arrhythmic outcomes in suspected cardiac sarcoidosis: a comparison of cardiovascular magnetic resonance phenotyping vs. societal recommendations for implantable cardioverter-defibrillator placement

Eur Heart JPublished

  • Cohort study
  • multicentre

Authors' conclusion

In patients with suspected cardiac sarcoidosis, CMR phenotyping showed greater discriminative accuracy than societal recommendations for predicting fatal or life-threatening ventricular arrhythmias

Study context

Population
Patients with histology-supported sarcoidosis undergoing CMR for suspected cardiac involvement, ineligible for secondary prevention implantable cardioverter-defibrillators (ICDs)84 with outcome
Participants
1,514 patients
Exposure
CMR phenotyping vs societal recommendations for primary prevention ICD placement
Outcome
Composite of:
  • Fatal
  • Life-threatening ventricular arrhythmias
Follow-up
Median 4.5 years; maximum 10 years

Main finding

As reported in the abstract

Fatal or life-threatening ventricular arrhythmias (composite) · 5 and 10 years
OutcomeHigh-risk CMR phenotypeLow-risk CMR phenotypeSocietal recommendations
5-year incidence24.0%0.7%Not reported in the abstract
10-year incidence35.0%2.6%Not reported in the abstract

Observational data: associations, not effects.

Original publication

Prediction of ventricular arrhythmic outcomes in suspected cardiac sarcoidosis: a comparison of cardiovascular magnetic resonance phenotyping vs. societal recommendations for implantable cardioverter-defibrillator placement. Eur Heart J. Published 22 May 2025. doi:10.1093/eurheartj/ehaf338

Summarised from the published abstract; every number is checked against it